XML 46 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Investment Products (CIP)
3 Months Ended
Mar. 31, 2021
Consolidated Investment Products [Abstract]  
CONSOLIDATED INVESTMENT PRODUCTS (CIP) CONSOLIDATED INVESTMENT PRODUCTS (CIP)
The following table presents the balances related to CIP that are included on the Condensed Consolidated Balance Sheets as well as Invesco’s net interest in the CIP for each period presented. See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.
As of
$ in millionsMarch 31, 2021December 31, 2020
Cash and cash equivalents of CIP429.6 301.7 
Accounts receivable and other assets of CIP258.4 175.5 
Investments of CIP7,912.1 7,910.0 
Less: Debt of CIP (6,700.9)(6,714.1)
Less: Other liabilities of CIP(663.6)(588.6)
Less: Retained earnings0.1 0.1 
Less: Accumulated other comprehensive income, net of tax— — 
Less: Equity attributable to redeemable noncontrolling interests(338.3)(211.8)
Less: Equity attributable to nonredeemable noncontrolling interests(481.7)(446.3)
Invesco’s net interests in CIP415.7 426.5 
The following table reflects the impact of consolidation of investment products into the Condensed Consolidated Statements of Income for the three months ended March 31, 2021 and 2020:
Three months ended March 31,
$ in millions20212020
Total operating revenues(10.1)(8.9)
Total operating expenses6.9 17.0 
Operating income(17.0)(25.9)
Equity in earnings of unconsolidated affiliates(34.3)(16.6)
Interest and dividend income— (0.1)
Other gains and losses, net1.2 41.8 
Interest and dividend income of CIP68.7 85.2 
Interest expense of CIP(40.9)(56.9)
Other gains/(losses) of CIP, net66.9 (48.4)
Income before income taxes44.6 (20.8)
Income tax provision— — 
Net income44.6 (20.8)
Net (income)/loss attributable to noncontrolling interests in consolidated entities
(44.6)20.7 
Net income attributable to Invesco Ltd.— (0.1)
Non-consolidated VIEs

At March 31, 2021, the company’s carrying value and maximum risk of loss with respect to variable interest entities (VIEs) in which the company is not the primary beneficiary was $150.9 million (December 31, 2020: $152.0 million).
Balance Sheet information - newly consolidated VIEs/VOEs

During the three months ended March 31, 2021, there were five newly consolidated variable interest entities (VIEs) and three newly consolidated voting rights entities (VOEs) (March 31, 2020: there were three newly consolidated VIEs and no newly consolidated VOEs. The table below illustrates the summary balance sheet amounts related to these products before consolidation into the company. The balances below are reflective of the balances existing at the consolidation date after the initial funding of the investments by the company and unrelated third-party investors. The current period activity for the consolidated funds, including the initial funding and subsequent investment of initial cash balances into underlying investments of CIP, is reflected in the company’s Condensed Consolidated Financial Statements.
For the three months ended March 31, 2021For the three months ended March 31, 2020
$ in millionsVIEsVOEsVIEsVOEs
Cash and cash equivalents of CIP0.1 — 2.4 — 
Accounts receivable and other assets of CIP— 1.0 0.1 — 
Investments of CIP13.6 131.4 26.3 — 
Total assets13.7 132.4 28.8 — 
Debt of CIP— — 2.0 — 
Other liabilities of CIP— 1.0 15.9 — 
Total liabilities— 1.0 17.9 — 
Total equity13.7 131.4 10.9 — 
Total liabilities and equity13.7 132.4 28.8 — 
Balance Sheet information - deconsolidated VIEs/VOEs

During the three months ended March 31, 2021, the company determined that it was no longer the primary beneficiary of five VIEs and no longer held the majority voting interest in three VOEs (March 31, 2020: the company determined that it was no longer the primary beneficiary of five VIEs and no longer held the majority voting interest in nine VOEs). The amounts deconsolidated from the Condensed Consolidated Balance Sheets are illustrated in the table below. There was no net impact to the Condensed Consolidated Statements of Income for the three months ended March 31, 2021 and 2020 from the deconsolidation of these investment products.
For the three months ended March 31, 2021For the three months ended March 31, 2020
$ in millionsVIEsVOEsVIEsVOEs
Cash and cash equivalents of CIP6.1 0.1 0.1 0.2 
Accounts receivable and other assets of CIP1.8 0.1 2.9 1.0 
Investments of CIP284.4 26.3 127.3 106.0 
Total assets292.3 26.5 130.3 107.2 
Debt of CIP— — — — 
Other liabilities of CIP17.3 — 1.5 — 
Total liabilities17.3 — 1.5 — 
Total equity275.0 26.5 128.8 107.2 
Total liabilities and equity292.3 26.5 130.3 107.2 
The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of March 31, 2021 and December 31, 2020:
As of March 31, 2021
$ in millionsFair Value MeasurementsQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV as a practical expedient
Assets:
Bank loans6,696.4 — 6,696.4 — — 
Bonds570.2 0.5 569.7 — — 
Equity securities353.3 258.1 95.2 — — 
Equity and fixed income mutual funds28.7 14.0 14.7 — — 
Investments in other private equity funds263.5 — 8.1 — 255.4 
Total assets at fair value7,912.1 272.6 7,384.1 — 255.4 
As of December 31, 2020
$ in millionsFair Value MeasurementsQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV as a practical expedient
Assets:
Bank loans6,864.5 — 6,864.5 — — 
Bonds539.0 0.6 538.4 — — 
Equity securities137.2 61.3 75.9 — — 
Equity and fixed income mutual funds103.0 91.2 11.8 — — 
Investments in other private equity funds266.3 — 8.1 — 258.2 
Total assets at fair value7,910.0 153.1 7,498.7 — 258.2 
The following tables show a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs:
Three months ended March 31, 2020
$ in millionsLevel 3 Assets
Beginning balance78.6 
Purchases— 
Gains and losses included in the Condensed Consolidated Statements of Income10.8 
Ending balance89.4 
The collateral assets held by consolidated CLOs are primarily invested in senior secured bank loans, bonds and equity securities. Bank loan investments of $6,679.6 million, which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans from a variety of industries, including but not limited to the aerospace and defense, broadcasting, technology, utilities, household products, healthcare, oil and gas and finance industries. Bank loan investments mature at various dates between 2020 and 2029, pay interest at LIBOR plus a spread of up to 11.0% and typically range in S&P credit rating categories from BBB down to unrated. Approximately less than 0.85% of the collateral assets were in default as of March 31, 2021 and 2020. Interest income on bank loans and bonds is recognized based on the unpaid principal balance and stated interest rate of these investments on an accrual basis. At March 31, 2021, the unpaid principal balance exceeds the fair value of the senior secured bank loans and bonds by approximately $87.1 million (December 31, 2020: the unpaid principal balance exceeded the fair value of the senior secured bank loans and bonds by approximately $208.6 million). These investments are accounted for on a one-month lag based on the availability of fund financial information, which means the first quarter fair value reflects a valuation as of February 28, 2021. CLO investments are valued based on price quotations provided by third-party pricing sources. These third-party sources aggregate indicative price quotations to provide the company with a
price for the CLO investments. The company has developed internal controls to review the reasonableness and completeness of these price quotations. If necessary, price quotations are challenged through a third-party pricing challenge process.

Notes issued by consolidated CLOs mature at various dates between 2021 and 2034 and have a weighted average maturity of 10.22 years. The notes are issued in various tranches with different risk profiles. The interest rates are generally variable rates based on LIBOR plus a pre-defined spread, which varies from 0.40% for the more senior tranches to 8.07% for the more subordinated tranches. The investors in this debt are not affiliated with the company and have no recourse to the general credit of the company for this debt.

The table below summarizes as of March 31, 2021 and December 31, 2020, the nature of investments that are valued using the NAV as a practical expedient and any related liquidation restrictions or other factors which may impact the ultimate value realized. These investments are valued on a three-month lag based on the availability of fund financial information.
March 31, 2021December 31, 2020
in millions, except term dataFair ValueTotal Unfunded Commitments
Weighted Average Remaining Term (2)
Fair ValueTotal Unfunded Commitments
Weighted Average Remaining Term (2)
Private equity funds (1)
$255.3 $110.16.6 years$258.2 $110.1 6.7 years
____________
(1)    These investments are not subject to redemption; however, for certain funds, the investors may sell or transfer their interest, which may require approval by the general partner of the underlying funds.
(2)    These investments are expected to be returned through distributions because of liquidations of the funds’ underlying assets over the weighted average periods indicated.